WO2004096748A1 - Preparation method of conjugated linoleic acid diglycerides - Google Patents

Preparation method of conjugated linoleic acid diglycerides Download PDF

Info

Publication number
WO2004096748A1
WO2004096748A1 PCT/KR2004/000511 KR2004000511W WO2004096748A1 WO 2004096748 A1 WO2004096748 A1 WO 2004096748A1 KR 2004000511 W KR2004000511 W KR 2004000511W WO 2004096748 A1 WO2004096748 A1 WO 2004096748A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
conjugated linoleic
linoleic acid
mixture
dglyceride
Prior art date
Application number
PCT/KR2004/000511
Other languages
French (fr)
Inventor
Dong- Hun Yoon
Gi- Wang Han
Soon-Gi Hong
Young-Ho Lee
Original Assignee
Ilshinwells Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020040015668A external-priority patent/KR100540875B1/en
Application filed by Ilshinwells Co., Ltd. filed Critical Ilshinwells Co., Ltd.
Priority to US10/510,700 priority Critical patent/US20050214434A1/en
Priority to EP04720283A priority patent/EP1618085A1/en
Priority to JP2005501731A priority patent/JP4212590B2/en
Publication of WO2004096748A1 publication Critical patent/WO2004096748A1/en
Priority to US12/416,821 priority patent/US8252948B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013Other fatty acid esters, e.g. phosphatides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/08Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with fatty acids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10Ester interchange
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6458Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6472Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a fat composition of high purity diglyceride comprising conjugated linoleic acid and a preparation method of the same. More particularly, the present invention relates to a lat composition of high purity diglyceride comprising conjugated linoleic acid and a preparation method thereof, which is simplified and provides a high production yield, while exhibiting high liinctionality when the conjugated linoleic acid or its isomer having various liinctions cf effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating diabetes, is bonded thereto.
  • Lipases are enzymes which hydrolyze lats and oils or esters of latty acids.
  • Glycerides synthesized by an esterification reaction are classified into mono- glycerides (MG), diglycerides (1,2-DG, 1,3-DG, 2,3-DG), and triglycerides (TG) according to the degree of substitution of hydroxyl group.
  • Diglycerides are lat compositions in which latty acid(s) and 1-, 2-, or 1- and
  • 3-position glycerin(s) are bonded by an esterification reaction and are classified differently from ordinary lats called triglycerides.
  • diglyceride has substantially the same digestion and absorption mechanisms as ordinary neutral lat and does not cause adverse physiological effects when ingested, such as a rise in the neutral lat level in human serum or accumulation of body lat, because little diglyceride is resynthesized to become neutral lat. Accordingly, research into preparation methods of such diglyceride is continuously being carried out.
  • Japanese Patent Laid-Open Publication Nos. showa 64-71495 and hei 11-123097 disclose methods of preparing lat compositions comprising diglyceride having a purity of 80 %, by hydrolyzing a lat into a latty acid and glycerin using a 1,3-positionally specific lipase, and resynthesizing the hydrolyzed fatty acid and glycerin. These methods, however, involve quite a complex mechanism, that is, hydrolyzed glycerin should be first dehydrated before being synthesized with fatty acid.
  • Conjugated linoleic acid is a conjugated isomer of linoleic acid (LA), which is an essential fatty acid that is a naturally occurring fatty acid found in the breast milk or muscle of ruminants in a trace amount.
  • LA linoleic acid
  • CLA is a general term used to name positional and geometric isomers of linoleic acid having conjugated double bonds in cis- or tr ⁇ ns-configuration.
  • physiologically liinctional cis - 9, trans-W octadecadienoic acid and trans- 10, cis- 12 octadecadienoic acid are specifically referred to as the CLA.
  • the CLA is excellent in reducing incidence of sclerosis of the artery (Artery, 1997, 22266-277), enhancing immunogenicity (J. Nut., 1999, 129:32-38) and anti-cancer activity (Anticancer research, 1997, 17:969-973), promoting growth (J. Nut, 2000, 1302931-2939) and therapeutic effects with respect to diabetes or other diseases. Further, the CLA has been reported to suppress obesity by reducing body lat (Am. J. Physiol., 1993, 275:R667-R672). By virtue cf such properties, the CLA can be advantageously used as the effective component of functional food and pharmaceutical products.
  • the present invention provides a fat composition of high purity dglyceride comprising conjugated linoleic acid having liinctions cf effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes.
  • the present invention provides a method of preparing a lat composition of high purity dglyceride comprising conjugated linoleic acid having liinctions of effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes, the preparation process of which is simple, and which provides a high production yield
  • the present invention liirther provides cosmetic emulsifiers, pharmaceutical emulsifiers, or highly liinctional food addtives having functions of effecting anti- cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes.
  • a lat composition of high purity dglyceride comprising 85% to 99.9% by weight of dglyceride containing 0.1 to 80 % by weight of conjugated linoleic acid, and the balance being monoglyceride, triglyceride or a mixture thereof.
  • a method of preparing a fat composition of high purity dglyceride comprising: mixing monoglyceride, conjugated linoleic acid; and lat, latty acid or a mixture therecf, and stirring the resulting mixture at 10 to 200 rpm; and subjecting the stirred mixture to an transes- terification at a temperature cf 200 to 250°C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours.
  • a method of preparing a fat composition of high purity dglyceride comprising: mixing monoglyceride, conjugated linoleic acid; and a lipase, and stirring the resulting mixture at 10 to 200 rpm; and subjecting the stirred mixture to an transesterification at a temperature cf 30 to 60°C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours.
  • cosmetic emulsifiers comprising the fat composition of high purity dglyceride containing conjugated linoleic acid prepared by the above-described method Mode for Invention
  • the present inventors conducted earnest studes based on the ideas that conjugated linoleic acid had liinctions of effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes and that the fat composition of high purity dglyceride comprising the conjugated linoleic acid would be advantageously useful as cosmetic emulsifiers, pharmaceutical emulsifiers, or highly functional food addtives.
  • the present invention has been completed on the basis of the above findng.
  • the lat composition of high purity dglyceride having functions of effecting anti- cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes could be prepared by a simplified preparation method, comprising mixing monoglyceride, conjugated linoleic acid, lat, latty acid or a mixture thereof and stirring the mixture at a speed of 10 to 200 rpm, and subjecting the stirred mixture to an transesterification at 200 to 250 °C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours.
  • the preparation method may comprise mixing monoglyceride, conjugated linoleic acid and a lipase and stirring at a speed of 10 to 200 rpm, and subjecting the stirred mixture to an transesterification at 30 to 60 °C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours.
  • the present inventors have completed the present invention based on such dscovery.
  • the conjugated linoleic acid is preferably contained in the dglyceride in an amount of 0.1 to 80 %.
  • the reason of specifically defining the preferred content of conjugated linoleic acid will now be described
  • the content of conjugated linoleic acid is less than 0.1 %, effects of the fat composition are negligible in view of liinctions of effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes.
  • the content of conjugated linoleic acid is greater than 80 %, the excess gives rise to a high cost of conjugated linoleic acid, increasing the preparation cost of high-purity dglyceride, which is not effective economically.
  • the preparation method of the fat composition of dglyceride containing conjugated linoleic acid proposed by the present inventors can be generally dvided into two categories.
  • the first category is to use fat, fatty acid or a mixture thereof: Monoglyceride, conjugated linoleic acid, and fat, fatty acid or a mixture thereof are mixed and stirred, and the stirred mixture is subjected to an transesterification.
  • the molar ratio of monoglyceride to fat, fatty acid or a mixture thereof is preferably in the range of 6:4 to 82.
  • the resulting mixture cf monoglyceride, conjugated linoleic acid, and fat, fatty acid or a mixture thereof is preferably stirred at a speed cf 10 to 200 rpm.
  • the stirring speed is less than 10 rpm, the stirring power is so weak that the reaction may be retarded
  • the stirring speed exceeds 200 rpm, the excess may result in degradation in product quality such as coloring.
  • the transesterification of the stirred mixture is preferably carried out at 200 to 250
  • the temperature cf the transesterification is more preferably in a range of 200 to 230 °C.
  • the reaction speed is slow.
  • the temperature of the transesterification exceeds 250 °C, the excess undesirably makes content control difficult.
  • the reduced pressure is less than 0.001 torr, in addtion to monoglyceride, dglyceride may also be dssolved during dstillation.
  • the reduced pressure is greater than 0.5 torr, dstillation of monoglyceride is difficult to achieve.
  • oils and fats useful in preparation of the fat composition of high purity dglyceride comprising conjugated linoleic acid include soybean oil, rapeseed oil, cotton-seed oil, corn oil, olive oil, palm oil, palm kernel oil, coconut oil, safflower oil and mixtures thereof.
  • saturated or unsaturated fatty acids having 2 to 24 carbon atoms include oleic acid, soybean fatty acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, linolenic acid, docosahexaenoic acid (DHA), and mixtures therecf. They can be used alone, or in combination with two or more compounds.
  • the second category is to use a lipase: Monoglyceride, conjugated linoleic acid, and a lipase are mixed and stirred, and the stirred mixture is subjected to a transesterification, which will now be described in more detail.
  • the conjugated linoleic acid can be prepared by isomerizing monoglyceride containing 1 to 80 parts by weight of linoleic acid based on 100 parts by weight of monoglyceride.
  • the conjugated linoleic acid in the mixture is preferably contained in an amount of
  • the present invention is not limited to the use of any particular lipase, preferably lypozyme, 1, 3-positionally specific lipase, positionally non-specific lipase, or 1, 3-positionally specific rhizopus, more preferably 1,3-positionally specific or positionally non-specific lipase.
  • the lipase is preferably contained in an amount of 0.1 to 20 parts by weight based on 100 parts by weight of monoglyceride.
  • the content of the lipase is less than 0.1 parts by weight, the shortage gives rise in a noticeable reduction in the conversion rate.
  • the content of the lipase is greater than 20 parts by weight, the economic efficiency is undesirably lowered
  • the monoglyceride, conjugated linoleic acid, and lipase are homogenized, followed by stirring at 10 to 200 rpm, more preferably at 150 rpm.
  • the transesterification of the stirred mixture is preferably carried out at 40 to 80 °C at a stirring speed cf 10 to 200 rpm for 1 to 10 hours.
  • the transesterification is carried out at a stirring speed cf 10 to 200 rpm, more preferably 150 rpm, and at a temperature in a range of 30 to 60 °C, more preferably 50 °C.
  • the stirring speed is lower than 10 rpm, the stirring power is so weak that the reaction speed may be retarded
  • the stirring speed exceeds 200 rpm, the excess gives rise to a fast, but uncontrollable, reaction.
  • the reaction temperature is lower than 40 °C, the reaction becomes slow.
  • the reaction temperature exceeds 80 °C, the reaction is facilitated but enzymes or other reaction factor may be adversely affected by heat.
  • the reaction time is shorter than 1 hour, the conversion efficiency is not high.
  • the thus-prepared fat composition accordng to the present invention preferably comprises 80 to 99.9 % by weight of dglyceride containing 0.1 to 80 % by weight of conjugated linoleic acid Although a trace amount of triglyceride or monoglyceride may be contained in the fat composition, to increase the purity of dglyceride, liirther performing molecular dstillation is preferred
  • the preparation process of a fat composition of dglyceride containing conjugated linoleic acid is simplified and a high production yield thereof can be provided
  • the conjugated linoleic acid having various functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes is bonded to the dglyceride, the functionalities can be enhanced
  • the present invention provides cosmetic emulsifiers, pharmaceutical emulsifiers or highly liinctional food addtives, particularly detary food addtives, comprising as an effective component fat composition of high purity dglyceride.
  • the cosmetic emulsifiers, pharmaceutical emulsifiers or highly functional food addtives, particularly detary food addtives advantageously exhibit various functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes.
  • Example 2 Into a 3 I round flask equipped with an stirrer were added 1200 g cf monoglyceride, 40 g of conjugated linoleic acid and 5 g of lipase for mixing, stirred at a stirring speed cf 150 rpm for solidifying, and reacted at 60 °C at a stirring speed cf 150 rpm for 10 minutes, thereby preparing a fat composition of dglyceride containing conjugated linoleic acid
  • Example 4 Into a 3 I flask were added 30 g of monoglyceride, 3 g of soybean fatty acid, 2 g of oleic acid, 65 g of conjugated linoleic acid, and slowly stirred for reaction under reduced pressure for 1 hour until the temperature reached 250 °C, followed by molecular dstillation under reduced pressure cf 0.04 torr at 250°C, giving a fat composition of dglyceride.
  • Example 5 The fat compositions prepared in Examples 1 to 3 were subjected to molecular dstillation using a dglyceride preparation processing system manufactured by Ilshin Emulsifier Co., Ltd, Korea until monoglyceride and triglyceride are all dstillation, and contents of dglycerides, e.g., 1,2-dglyceride, 1,3-dglyceride, and conjugated linoleic acid bonded to dglyceride, were measured The measurement results are shown in Table 2.
  • the fat composition of high purity dglyceride can be simply prepared at a high production yield, while exhibiting high functionality when it is bonded to conjugated linoleic acid having functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes.
  • the fat composition of high purity dglyceride accordng to the present invention can be used for cosmetic emulsifiers, pharmaceutical emulsifiers or detary food addtives as highly functional food addtives having various functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes, because the fat composition is not dgested and absorbed into the body as body fat.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

A fat composition o high purity diglyceride containing conjugated linoleic acid and a preparation method thereof are provided. The fat composition comprises 85% to 99.9% by weight of diglyceride containing 0.1 to 80% by weight of conjugated linoleic acid, and the balance being monoglyceride, triglyceride or a mixture thereof. The fat composition can be used in highly functional food additives owing to conjugated linoleic acid having various functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating diabetes, and can be simply prepared at a high production yield.

Description

Description
Preparation method of conjugated linoleic acid diglycerides
Technical Field
[1] The present invention relates to a fat composition of high purity diglyceride comprising conjugated linoleic acid and a preparation method of the same. More particularly, the present invention relates to a lat composition of high purity diglyceride comprising conjugated linoleic acid and a preparation method thereof, which is simplified and provides a high production yield, while exhibiting high liinctionality when the conjugated linoleic acid or its isomer having various liinctions cf effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating diabetes, is bonded thereto.
Background Art
[2] Lipases are enzymes which hydrolyze lats and oils or esters of latty acids.
However, it is known that, under certain conditions, lipases cause an esterification reaction and thereby glycerides or esters can be synthesized from a latty acid and glycerol or from a latty acid and an alcohol (J. Gen. Appl. MicrobioL, 10, 13-22, 1964; Proc. IV IFS: Ferment. Technol. Today, 315-320, 19E, issued by Society cf Fermentation Technology Japan ; Biochim. Biophys. Acta, 489, 415-422, 1977; Bull.)
[3] Glycerides synthesized by an esterification reaction are classified into mono- glycerides (MG), diglycerides (1,2-DG, 1,3-DG, 2,3-DG), and triglycerides (TG) according to the degree of substitution of hydroxyl group.
[4] Diglycerides are lat compositions in which latty acid(s) and 1-, 2-, or 1- and
3-position glycerin(s) are bonded by an esterification reaction and are classified differently from ordinary lats called triglycerides.
[5] Recently, it has been reported that diglyceride has substantially the same digestion and absorption mechanisms as ordinary neutral lat and does not cause adverse physiological effects when ingested, such as a rise in the neutral lat level in human serum or accumulation of body lat, because little diglyceride is resynthesized to become neutral lat. Accordingly, research into preparation methods of such diglyceride is continuously being carried out.
[6] One of those preparation methods of diglyceride is disclosed in Japanese Patent
Laid-Open Publication No. Hei 6-343481, in which solid lat is reacted with a lipase derived from glycerin or microorganisms of genera Pseudomonas, yielding 85% diglyceride. However, this method has drawbacks that formation of the solid fat requires a room temperature condition and it is quite difficult to obtain diglyceride having a purity of higher than 85 % from liquid fat.
[7] Japanese Patent Laid-Open Publication Nos. showa 64-71495 and hei 11-123097 disclose methods of preparing lat compositions comprising diglyceride having a purity of 80 %, by hydrolyzing a lat into a latty acid and glycerin using a 1,3-positionally specific lipase, and resynthesizing the hydrolyzed fatty acid and glycerin. These methods, however, involve quite a complex mechanism, that is, hydrolyzed glycerin should be first dehydrated before being synthesized with fatty acid.
[8] To overcome the aforementioned problems, a preparation method of a fat composition containing diglyceride of a purity of higher than 60% has been proposed in Korean Patent Application No. 2001-0002974, in which water and a 1,3-positionally specific lipase or a nonspecific lipase are used. However, this technique also presents some problems that the content of free fatty acids may increase due to a side reaction occurring after the reaction, i.e., hydrolysis of fatty acids in the diglyceride having a purity of higher than 60 % in the presence of water, requiring an additional step of removing the free fatty acids. Also, byproducts containing 40% of free fatty acids should be further processed for filtration.
[9] It would, therefore, be highly demanded to conduct research into preparation methods of a high purity diglyceride fat composition, which is simplified and provides a high production yield.
[10] Conjugated linoleic acid (CLA) is a conjugated isomer of linoleic acid (LA), which is an essential fatty acid that is a naturally occurring fatty acid found in the breast milk or muscle of ruminants in a trace amount. CLA is a general term used to name positional and geometric isomers of linoleic acid having conjugated double bonds in cis- or trαns-configuration. Among those CLA isomers, physiologically liinctional cis - 9, trans-W octadecadienoic acid and trans- 10, cis- 12 octadecadienoic acid are specifically referred to as the CLA. The CLA is excellent in reducing incidence of sclerosis of the artery (Artery, 1997, 22266-277), enhancing immunogenicity (J. Nut., 1999, 129:32-38) and anti-cancer activity (Anticancer research, 1997, 17:969-973), promoting growth (J. Nut, 2000, 1302931-2939) and therapeutic effects with respect to diabetes or other diseases. Further, the CLA has been reported to suppress obesity by reducing body lat (Am. J. Physiol., 1993, 275:R667-R672). By virtue cf such properties, the CLA can be advantageously used as the effective component of functional food and pharmaceutical products.
Disclosure
[11] To solve the above problems, the present invention provides a fat composition of high purity dglyceride comprising conjugated linoleic acid having liinctions cf effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes.
[12] Also, the present invention provides a method of preparing a lat composition of high purity dglyceride comprising conjugated linoleic acid having liinctions of effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes, the preparation process of which is simple, and which provides a high production yield
[13] The present invention liirther provides cosmetic emulsifiers, pharmaceutical emulsifiers, or highly liinctional food addtives having functions of effecting anti- cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes.
[14] In an aspect of the present invention, there is provided a lat composition of high purity dglyceride comprising 85% to 99.9% by weight of dglyceride containing 0.1 to 80 % by weight of conjugated linoleic acid, and the balance being monoglyceride, triglyceride or a mixture thereof.
[15] In another aspect of the present invention, there is provided a method of preparing a fat composition of high purity dglyceride, the method comprising: mixing monoglyceride, conjugated linoleic acid; and lat, latty acid or a mixture therecf, and stirring the resulting mixture at 10 to 200 rpm; and subjecting the stirred mixture to an transes- terification at a temperature cf 200 to 250°C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours.
[16] In still another aspect of the present invention, there is provided a method of preparing a fat composition of high purity dglyceride, the method comprising: mixing monoglyceride, conjugated linoleic acid; and a lipase, and stirring the resulting mixture at 10 to 200 rpm; and subjecting the stirred mixture to an transesterification at a temperature cf 30 to 60°C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours.
[17] In still further aspect of the present invention, there is provided cosmetic emulsifiers, pharmaceutical emulsifiers or highly functional food addtives comprising the fat composition of high purity dglyceride containing conjugated linoleic acid prepared by the above-described method Mode for Invention
[18] The present invention will now be described in detail.
[19] The present inventors conducted earnest studes based on the ideas that conjugated linoleic acid had liinctions of effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes and that the fat composition of high purity dglyceride comprising the conjugated linoleic acid would be advantageously useful as cosmetic emulsifiers, pharmaceutical emulsifiers, or highly functional food addtives. The present invention has been completed on the basis of the above findng.
[20] Also, as a result of the present inventors' studes cf simplified, high-yield preparation methods of a lat composition of high purity dglyceride, it was dscovered that the lat composition of high purity dglyceride having functions of effecting anti- cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes could be prepared by a simplified preparation method, comprising mixing monoglyceride, conjugated linoleic acid, lat, latty acid or a mixture thereof and stirring the mixture at a speed of 10 to 200 rpm, and subjecting the stirred mixture to an transesterification at 200 to 250 °C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours. Alternatively, the preparation method may comprise mixing monoglyceride, conjugated linoleic acid and a lipase and stirring at a speed of 10 to 200 rpm, and subjecting the stirred mixture to an transesterification at 30 to 60 °C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours. The present inventors have completed the present invention based on such dscovery.
[21] In the fat composition of high purity dglyceride containing conjugated linoleic acid accordng to the present invention, the conjugated linoleic acid is preferably contained in the dglyceride in an amount of 0.1 to 80 %. The reason of specifically defining the preferred content of conjugated linoleic acid will now be described When the content of conjugated linoleic acid is less than 0.1 %, effects of the fat composition are negligible in view of liinctions of effecting anti-cancer activity, reducing human body lat, enhancing immunogenicity, and preventing and/or treating dabetes. When the content of conjugated linoleic acid is greater than 80 %, the excess gives rise to a high cost of conjugated linoleic acid, increasing the preparation cost of high-purity dglyceride, which is not effective economically.
[22] The preparation method of the fat composition of dglyceride containing conjugated linoleic acid proposed by the present inventors can be generally dvided into two categories. [23] The first category is to use fat, fatty acid or a mixture thereof: Monoglyceride, conjugated linoleic acid, and fat, fatty acid or a mixture thereof are mixed and stirred, and the stirred mixture is subjected to an transesterification.
[24] (a) Mixing and stirring monoglyceride. conjugated linoleic acid, and fat, fatty acid or a mixture thereof
[25] The reaction condtions will now be described in more detail. First, monoglyceride, conjugated linoleic acid, and fat, fatty acid or a mixture thereof are mixed and stirred In the stirring step, the mixing cf monoglyceride, conjugated linoleic acid, and fat, fatty acid or a mixture thereof is preferably performed by addng 35 to 65 parts by weight of conjugated linoleic acid and 20 to 80 parts by weight of fat, fatty acid or a mixture thereof, based on 100 parts by weight of monoglyceride.
[26] In the mixture, the molar ratio of monoglyceride to fat, fatty acid or a mixture thereof is preferably in the range of 6:4 to 82.
[27] The resulting mixture cf monoglyceride, conjugated linoleic acid, and fat, fatty acid or a mixture thereof is preferably stirred at a speed cf 10 to 200 rpm. When the stirring speed is less than 10 rpm, the stirring power is so weak that the reaction may be retarded When the stirring speed exceeds 200 rpm, the excess may result in degradation in product quality such as coloring.
[28] (b) Subjecting stirred mixture to transesterification
[29] The transesterification of the stirred mixture is preferably carried out at 200 to 250
°C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours. The temperature cf the transesterification is more preferably in a range of 200 to 230 °C. When the temperature cf the transesterification is lower than 200 °C, the reaction speed is slow. When the temperature of the transesterification exceeds 250 °C, the excess undesirably makes content control difficult. Also, when the reduced pressure is less than 0.001 torr, in addtion to monoglyceride, dglyceride may also be dssolved during dstillation. When the reduced pressure is greater than 0.5 torr, dstillation of monoglyceride is difficult to achieve.
[30] Examples of oils and fats useful in preparation of the fat composition of high purity dglyceride comprising conjugated linoleic acid include soybean oil, rapeseed oil, cotton-seed oil, corn oil, olive oil, palm oil, palm kernel oil, coconut oil, safflower oil and mixtures thereof. Examples of saturated or unsaturated fatty acids having 2 to 24 carbon atoms include oleic acid, soybean fatty acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, linolenic acid, docosahexaenoic acid (DHA), and mixtures therecf. They can be used alone, or in combination with two or more compounds.
[31] The second category is to use a lipase: Monoglyceride, conjugated linoleic acid, and a lipase are mixed and stirred, and the stirred mixture is subjected to a transesterification, which will now be described in more detail.
[32] (a) Mixing and stirring monoglyceride. conjugated linoleic acid, and lipase
[33] In this step, monoglyceride, conjugated linoleic acid, and a lipase are mixed and stirred
[34] The conjugated linoleic acid can be prepared by isomerizing monoglyceride containing 1 to 80 parts by weight of linoleic acid based on 100 parts by weight of monoglyceride.
[35] The conjugated linoleic acid in the mixture is preferably contained in an amount of
1 to 80 parts by weight, based on 100 parts by weight of monoglyceride. When the amount of the conjugated linoleic acid is less than 1 part, the functionality thereof may be lowered When the amount of the conjugated linoleic acid is greater than 80 parts, the excess is not cost-effective.
[36] The present invention is not limited to the use of any particular lipase, preferably lypozyme, 1, 3-positionally specific lipase, positionally non-specific lipase, or 1, 3-positionally specific rhizopus, more preferably 1,3-positionally specific or positionally non-specific lipase.
[37] The lipase is preferably contained in an amount of 0.1 to 20 parts by weight based on 100 parts by weight of monoglyceride. When the content of the lipase is less than 0.1 parts by weight, the shortage gives rise in a noticeable reduction in the conversion rate. When the content of the lipase is greater than 20 parts by weight, the economic efficiency is undesirably lowered
[38] It is preferable that the monoglyceride, conjugated linoleic acid, and lipase are homogenized, followed by stirring at 10 to 200 rpm, more preferably at 150 rpm.
[39] (b) Subjecting stirred mixture to transesterification
[40] The transesterification of the stirred mixture is preferably carried out at 40 to 80 °C at a stirring speed cf 10 to 200 rpm for 1 to 10 hours. Preferably, the transesterification is carried out at a stirring speed cf 10 to 200 rpm, more preferably 150 rpm, and at a temperature in a range of 30 to 60 °C, more preferably 50 °C. When the stirring speed is lower than 10 rpm, the stirring power is so weak that the reaction speed may be retarded When the stirring speed exceeds 200 rpm, the excess gives rise to a fast, but uncontrollable, reaction. Also, when the reaction temperature is lower than 40 °C, the reaction becomes slow. When the reaction temperature exceeds 80 °C, the reaction is facilitated but enzymes or other reaction factor may be adversely affected by heat. Also, when the reaction time is shorter than 1 hour, the conversion efficiency is not high.
[41] After performing the preparation method of the fat composition of high purity dglyceride containing conjugated linoleic acid by the above-described method dvided into two categories, monoglyceride, triglyceride, or fatty acids contained in the fat composition are removed by molecular dstillation, thereby acquiring a fat composition containing at least 80 % by weight of dglyceride.
[42] The thus-prepared fat composition accordng to the present invention preferably comprises 80 to 99.9 % by weight of dglyceride containing 0.1 to 80 % by weight of conjugated linoleic acid Although a trace amount of triglyceride or monoglyceride may be contained in the fat composition, to increase the purity of dglyceride, liirther performing molecular dstillation is preferred
[43] As described above, accordng to the present invention, the preparation process of a fat composition of dglyceride containing conjugated linoleic acid is simplified and a high production yield thereof can be provided Also, when the conjugated linoleic acid having various functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes, is bonded to the dglyceride, the functionalities can be enhanced
[44] Also, the present invention provides cosmetic emulsifiers, pharmaceutical emulsifiers or highly liinctional food addtives, particularly detary food addtives, comprising as an effective component fat composition of high purity dglyceride. The cosmetic emulsifiers, pharmaceutical emulsifiers or highly functional food addtives, particularly detary food addtives advantageously exhibit various functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes.
[45] A further understandng can be obtained by reference to certain preferred examples which are provided herein for purposes of illustration only and are not intended to be limiting unless otherwise specified
[46] EXAMPLES
[47] Example 1
[48] Into a 3 I round flask equipped with an stirrer were added 1300 g cf monoglyceride, 20 g of conjugated linoleic acid and 5 g of lipase for mixing, stirred at a stirring speed cf 150 rpm for solidifying, and reacted at 60 °C at a stirring speed cf 150 rpm for 10 hours, thereby preparing a fat composition of dglyceride containing conjugated linoleic acid
[49] Example 2 [50] Into a 3 I round flask equipped with an stirrer were added 1200 g cf monoglyceride, 40 g of conjugated linoleic acid and 5 g of lipase for mixing, stirred at a stirring speed cf 150 rpm for solidifying, and reacted at 60 °C at a stirring speed cf 150 rpm for 10 minutes, thereby preparing a fat composition of dglyceride containing conjugated linoleic acid
[51] Example 3
Into a 3 I round flask equipped with an stirrer were added 1000 g of monoglyceride, 80 g of conjugated linoleic acid and 5 g of lipase for mixing, stirred at a stirring speed cf 150 rpm for solidifying, and reacted at 60 °C at a stirring speed cf 150 rpm for 2 hours, thereby preparing a fat composition of dglyceride containing conjugated linoleic acid
[53] Example 4 [54] Into a 3 I flask were added 30 g of monoglyceride, 3 g of soybean fatty acid, 2 g of oleic acid, 65 g of conjugated linoleic acid, and slowly stirred for reaction under reduced pressure for 1 hour until the temperature reached 250 °C, followed by molecular dstillation under reduced pressure cf 0.04 torr at 250°C, giving a fat composition of dglyceride. Contents of monoglyceride, dglyceride, and triglyceride of the fat composition of dglyceride prepared in Example 4 and a content of conjugated linoleic acid bonded to the fat composition of dglyceride were measured and listed in Table 1.
[55] Table 1 [56]
Figure imgf000009_0001
[57] Example 5 [58] The fat compositions prepared in Examples 1 to 3 were subjected to molecular dstillation using a dglyceride preparation processing system manufactured by Ilshin Emulsifier Co., Ltd, Korea until monoglyceride and triglyceride are all dstillation, and contents of dglycerides, e.g., 1,2-dglyceride, 1,3-dglyceride, and conjugated linoleic acid bonded to dglyceride, were measured The measurement results are shown in Table 2.
[59] Table 2 [60]
Figure imgf000010_0001
[61] (Unit: % by weight)
Industrial Applicability
[62] Accordng to the present invention, the fat composition of high purity dglyceride can be simply prepared at a high production yield, while exhibiting high functionality when it is bonded to conjugated linoleic acid having functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes. The fat composition of high purity dglyceride accordng to the present invention can be used for cosmetic emulsifiers, pharmaceutical emulsifiers or detary food addtives as highly functional food addtives having various functions of effecting anti-cancer activity, reducing human body fat, enhancing immunogenicity, and preventing and/or treating dabetes, because the fat composition is not dgested and absorbed into the body as body fat.

Claims

Claims
[1] A fat composition of high purity dglyceride comprising:
85% to 99.9 % by weight of dglyceride containing 0.1 to 80 % by weight of conjugated linoleic acid; and the balance being monoglyceride, triglyceride or a mixture thereof. [2] A method of preparing a fat composition of high purity dglyceride containing conjugated linoleic acid, the method comprising: mixing monoglyceride, conjugated linoleic acid, and fat, fatty acid or a mixture therecf and stirring the mixture at a speed cf 10 to 200 rpm; and subjecting the stirred mixture to an transesterification at 200 250 °C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours. [3] The method of claim 2, wherein the molar ratio of monoglyceride to fat, fatty acid or a mixture thereof is preferably in the range of 6:4 to 82. [4] The method of claim 2, wherein the temperature of the transesterification is in a range of 200 to 230 °C. [5] The method of claim 2, wherein the oil or fat is selected from the group consisting of soybean oil, rapeseed oil, cotton-seed oil, corn oil, olive oil, palm oil, palm kernel oil, coconut oil, safflower oil and mixtures thereof. [6] The method of claim 2, wherein the fatty acid is a saturated or unsaturated fatty acid having 2 to 24 carbon atoms selected form the group consisting of oleic acid, soybean fatty acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, and linolenic acid, docosahexaenoic acid (DHA), and mixtures therecf. [7] A method cf preparing a fat composition cf high purity dglyceride containing conjugated linoleic acid, the method comprising: mixing monoglyceride, conjugated linoleic acid, and a lipase and stirring the mixture at a speed cf 10 to 200 rpm; and subjecting the stirred mixture to an transesterification at 30 60 °C under reduced pressure cf 0.001 to 0.5 torr for 1 to 10 hours. [8] The method of claim 7, after the subjecting cf the transesterification, further comprising performing molecular dstillation on the mixture. [9] The method of claim 7, wherein the amount of conjugated linoleic acid is 1 to 80 parts by weight based on 100 parts by weight of monoglyceride and the amount of lipase is 0.1 to 20 parts by weight based on 100 parts by weight of mono- glyceride.
[10] The method of claim 7, wherein the lipase is selected from the group consisting of lypozyme, 1,3-positionally specific lipase, positionally non-specific lipase, 1,3-positionally specific rhizopus, or geotrios having unsaturated fatty acid specificity, more preferably 1,3-positionally specific or positionally non-specific lipase.
[11] Cosmetic emulsifiers, pharmaceutical emulsifiers or highly functional food addtives, comprising a fat composition of high purity dglyceride containing conjugated linoleic acid prepared by the method of claim 2 or 7.
PCT/KR2004/000511 2003-04-25 2004-03-12 Preparation method of conjugated linoleic acid diglycerides WO2004096748A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/510,700 US20050214434A1 (en) 2003-04-25 2004-03-12 Preparation method of the conjugated linoleic acid diglycerides
EP04720283A EP1618085A1 (en) 2003-04-25 2004-03-12 Preparation method of conjugated linoleic acid diglycerides
JP2005501731A JP4212590B2 (en) 2003-04-25 2004-03-12 High purity diglyceride oil composition containing conjugated linoleic acid and method for producing the same
US12/416,821 US8252948B2 (en) 2003-04-25 2009-04-01 Fat composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2003-0026515 2003-04-25
KR20030026515 2003-04-25
KR10-2004-0015668 2004-03-09
KR1020040015668A KR100540875B1 (en) 2003-04-25 2004-03-09 Fat composition of high degree of purity diglyceride comprising conjugated linoleic acid and preparation method of the same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/510,700 A-371-Of-International US20050214434A1 (en) 2003-04-25 2004-03-12 Preparation method of the conjugated linoleic acid diglycerides
US12/416,821 Continuation-In-Part US8252948B2 (en) 2003-04-25 2009-04-01 Fat composition

Publications (1)

Publication Number Publication Date
WO2004096748A1 true WO2004096748A1 (en) 2004-11-11

Family

ID=36383771

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2004/000511 WO2004096748A1 (en) 2003-04-25 2004-03-12 Preparation method of conjugated linoleic acid diglycerides

Country Status (4)

Country Link
US (1) US20050214434A1 (en)
EP (1) EP1618085A1 (en)
JP (1) JP4212590B2 (en)
WO (1) WO2004096748A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1733012A1 (en) * 2003-11-28 2006-12-20 Onbio Corporation A composition enriched in diglyceride with conjugated linoleic acid
WO2007097523A2 (en) * 2006-02-24 2007-08-30 Ilshin Wells Co., Ltd. Fat composition and preparation methods thereof
US8853192B2 (en) 2006-08-11 2014-10-07 Kao Corporation Fat or oil composition

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070218183A1 (en) * 2006-03-14 2007-09-20 Bunge Oils, Inc. Oil composition of conjugated linoleic acid
JP5101206B2 (en) * 2007-08-08 2012-12-19 花王株式会社 Process for producing fats and oils with high diacylglycerol content
US20090202704A1 (en) * 2008-02-13 2009-08-13 Kao Corporation Postprandial hyperglycemia-improving agent
US20110076358A1 (en) * 2008-05-29 2011-03-31 Kao Corporation Process for producing diacylglycerol-rich fat or oil
EP2432328A1 (en) * 2009-05-22 2012-03-28 Stepan Specialty Products, LLC Fat blends and uses thereof
JP6002504B2 (en) * 2011-08-22 2016-10-05 花王株式会社 Oil composition
WO2015135961A1 (en) * 2014-03-13 2015-09-17 Basf Se Pelleted ruminant feed enriched with rumen-available ingredients
CN105112464B (en) * 2015-08-19 2018-10-09 嘉必优生物技术(武汉)股份有限公司 Structure grease and special diet comprising the Structure grease
US11466231B2 (en) 2018-06-05 2022-10-11 Dsm Ip Assets B.V. Process for the production of diglycerides

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461170A (en) * 1987-10-14 1995-10-24 Kao Corporation Process for preparation of polyol fatty acid ester and glyceride mixture obtained
EP0954975A2 (en) * 1998-05-04 1999-11-10 ConLinCo, Inc. Isomer enriched conjugated linoleic acid compositions
US6177580B1 (en) * 1998-04-21 2001-01-23 Henkel Kommanditgesellschaft Auf Aktien Conjugated linolenic acid-based synthetic triglycerides
EP1097708A1 (en) * 1999-11-02 2001-05-09 Unilever N.V. Use of trans-trans isomers of conjugated linoleic acid
EP1174416A1 (en) * 1999-04-27 2002-01-23 Kabushiki Kaisha Yakult Honsha Conjugated fatty acid esters
US6432453B1 (en) * 2000-08-26 2002-08-13 Metagenics, Inc. Dietary supplement containing glycerol ester of conjugated linoleic acid and rosemary extract containing carnosic acid
US20020147356A1 (en) * 2000-11-21 2002-10-10 Bonsignore Patrick V. Bioactive conjugated linoleic acid glycerides and method of use
EP1281750A2 (en) * 2001-08-02 2003-02-05 Rinoru Oil Mills Co., Ltd. Conjugated fatty acid containing monoglycerides and process for producing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0113105A (en) * 2000-08-08 2003-07-08 Kao Corp Oil / fat composition
JP4157765B2 (en) * 2002-02-18 2008-10-01 花王株式会社 Powdered oil

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461170A (en) * 1987-10-14 1995-10-24 Kao Corporation Process for preparation of polyol fatty acid ester and glyceride mixture obtained
US6177580B1 (en) * 1998-04-21 2001-01-23 Henkel Kommanditgesellschaft Auf Aktien Conjugated linolenic acid-based synthetic triglycerides
EP0954975A2 (en) * 1998-05-04 1999-11-10 ConLinCo, Inc. Isomer enriched conjugated linoleic acid compositions
EP1174416A1 (en) * 1999-04-27 2002-01-23 Kabushiki Kaisha Yakult Honsha Conjugated fatty acid esters
EP1097708A1 (en) * 1999-11-02 2001-05-09 Unilever N.V. Use of trans-trans isomers of conjugated linoleic acid
US6432453B1 (en) * 2000-08-26 2002-08-13 Metagenics, Inc. Dietary supplement containing glycerol ester of conjugated linoleic acid and rosemary extract containing carnosic acid
US20020147356A1 (en) * 2000-11-21 2002-10-10 Bonsignore Patrick V. Bioactive conjugated linoleic acid glycerides and method of use
EP1281750A2 (en) * 2001-08-02 2003-02-05 Rinoru Oil Mills Co., Ltd. Conjugated fatty acid containing monoglycerides and process for producing them

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1733012A1 (en) * 2003-11-28 2006-12-20 Onbio Corporation A composition enriched in diglyceride with conjugated linoleic acid
EP1733012A4 (en) * 2003-11-28 2009-08-05 Onbio Corp A composition enriched in diglyceride with conjugated linoleic acid
WO2007097523A2 (en) * 2006-02-24 2007-08-30 Ilshin Wells Co., Ltd. Fat composition and preparation methods thereof
WO2007097523A3 (en) * 2006-02-24 2007-10-25 Ilshin Wells Co Ltd Fat composition and preparation methods thereof
US8853192B2 (en) 2006-08-11 2014-10-07 Kao Corporation Fat or oil composition

Also Published As

Publication number Publication date
JP4212590B2 (en) 2009-01-21
US20050214434A1 (en) 2005-09-29
EP1618085A1 (en) 2006-01-25
JP2006513307A (en) 2006-04-20

Similar Documents

Publication Publication Date Title
US7767427B2 (en) Production method of oil or fat containing polyunsaturated fatty acid-containing triglyceride
US6184009B1 (en) Process for the preparation of materials with a high content of conjugated long chain polyunsaturated fatty acids
JP4530311B2 (en) Method for producing glyceride using lipase
EP1966387B1 (en) Process for the production of diacylglycerol
KR100598607B1 (en) Oil composition and preparation method thereof
CA2800674A1 (en) Method for producing oil containing polyunsaturated fatty acid using lipase
EP2682453B1 (en) Method of producing oil/fat comprising highly-unsaturated fatty acids by means of lipase
EP1281750B1 (en) Conjugated fatty acid containing monoglycerides and process for producing them
US20050214434A1 (en) Preparation method of the conjugated linoleic acid diglycerides
CN111172211A (en) Method for preparing long-chain polyunsaturated fatty acid glyceride rich in fish oil n-3 by enzyme method and product thereof
CN111172210A (en) Method for preparing arachidonic acid glyceride rich by two-step enzyme method and product thereof
KR100540875B1 (en) Fat composition of high degree of purity diglyceride comprising conjugated linoleic acid and preparation method of the same
CN109666709B (en) Method for preparing diglyceride by using high-acid-value grease as raw material
CN111363766B (en) Preparation method of structural lipid for improving DHA bioavailability and product thereof
JP4310387B2 (en) Omega-3 highly unsaturated fatty acid-containing partial glyceride composition and method for producing the same
JP3861941B2 (en) Oil composition containing highly unsaturated fatty acid with improved hydration
TWI296653B (en) Fat composition of high purity diglyceride comprising conjugated linoleic acid and preparation method of the same
KR20180121718A (en) Improved method for preparing monoacylglycerol by using enzymatic alcoholysis

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2005501731

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 10510700

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 20048001155

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2004720283

Country of ref document: EP

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2004720283

Country of ref document: EP